Four versus Six Cycles of Pemetrexed/Platinum as a First Line Treatment of Malignant Pleural Mesothelima: Results of a Randomized Phase II Study

Oncology Research · Volume 0, Issue 1 (2018) · pp. 1–3

DOI: 10.21608/resoncol.2018.4306.1062

Abstract

No abstract